Resources
Get helpful information about MRD and M-inSight®
All
Articles
Documentation
Events
Posters
Publications
Clonotypic Peptide Mass Spectrometry to Define Functional Cure in Patients with Multiple Myeloma Undergoing Maintenance Cessation - ASH 2024
MRD tracking in blood using a de novo sequencing from SPEP gel of M-protein in Multiple Myeloma Patients - IMS 2024
Advances in minimal residual disease monitoring in multiple myeloma - Clinical Laboratory Sciences 2023
Single MS assay targeting m-protein, therapeutic antibodies, polyclonal immunoglobulins provides unique insight into therapy response kinetics in patients with MM - EMN 2024
An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and MRD monitoring in MM patients - CCLM 2024
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator - CCLM 2024
Monitoring of Systemic Light-Chain Amyloidosis patients using Mass Spectrometry (M-inSight) in serum - ASH 2023
